Inhibition of CYP2B6 by Medicinal Plant Extracts: Implication for Use of Efavirenz and Nevirapine-Based Highly Active Anti-Retroviral Therapy (HAART) in Resource-Limited Settings
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of CYP2B6 by Medicinal Plant Extracts: Implication for Use of Efavirenz and Nevirapine-Based Highly Active Anti-Retroviral Therapy (HAART) in Resource-Limited Settings
Authors
Keywords
-
Journal
MOLECULES
Volume 21, Issue 2, Pages 211
Publisher
MDPI AG
Online
2016-02-16
DOI
10.3390/molecules21020211
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship*
- (2014) Nilesh B. Bhatt et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of Inhibitory Effects of Caffeic acid and Quercetin on Human Liver Cytochrome P450 Activities
- (2014) Himanshu Rastogi et al. PHYTOTHERAPY RESEARCH
- Evaluation of drug interaction potential of Labisia pumila (Kacip Fatimah) and its constituents
- (2014) Vamshi K. Manda et al. Frontiers in Pharmacology
- The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study
- (2013) Ane Djuv et al. BMC Complementary and Alternative Medicine
- Dyslipidemia and fasting glucose impairment among HIV patients three years after the first antiretroviral regimen in a Brazilian AIDS outpatient clinic
- (2013) Lauro Ferreira da Silva Pinto Neto et al. Brazilian Journal of Infectious Diseases
- Phytochemical constituents, antioxidant properties and p-coumaric acid analysis in some seagrasses
- (2013) Rengasamy Ragupathi Raja Kannan et al. FOOD RESEARCH INTERNATIONAL
- Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance
- (2013) Ulrich M. Zanger et al. Frontiers in Genetics
- Herb-Drug Interactions and Mechanistic and Clinical Considerations
- (2012) Xiao-Wu Chen et al. CURRENT DRUG METABOLISM
- Herbal Medicines for the Prevention and Treatment of Alzheimer's Disease
- (2012) Hyo Geun Kim et al. CURRENT PHARMACEUTICAL DESIGN
- Metabolome Classification of CommercialHypericum perforatum(St. John's Wort) Preparations via UPLC-qTOF-MS and Chemometrics
- (2012) Mohamed Farag et al. PLANTA MEDICA
- Liver Enzyme Abnormalities and Associated Risk Factors in HIV Patients on Efavirenz-Based HAART with or without Tuberculosis Co-Infection in Tanzania
- (2012) Sabina Mugusi et al. PLoS One
- Herbal Extracts and Phytochemicals: Plant Secondary Metabolites and the Enhancement of Human Brain function
- (2012) David O. Kennedy et al. Advances in Nutrition
- Clinical Herbal Interactions with Conventional Drugs: From Molecules to Maladies
- (2011) X.-W. Chen et al. CURRENT MEDICINAL CHEMISTRY
- ADME Properties of Herbal Medicines in Humans: Evidence, Challenges and Strategies
- (2011) Shu-Ming He et al. CURRENT PHARMACEUTICAL DESIGN
- A Refined Cytochrome P450 IC50 Shift Assay for Reliably Identifying CYP3A Time-Dependent Inhibitors
- (2011) P. Li et al. DRUG METABOLISM AND DISPOSITION
- High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study
- (2011) G Yimer et al. PHARMACOGENOMICS JOURNAL
- Dyslipidemia and lipid management in HIV-infected patients
- (2011) Janet Lo Current Opinion in Endocrinology Diabetes and Obesity
- Biological analysis of herbal medicines used for the treatment of liver diseases
- (2010) Chao-Feng Chien et al. BIOMEDICAL CHROMATOGRAPHY
- Liver Disease in the HIV–Infected Individual
- (2010) Jennifer C. Price et al. Clinical Gastroenterology and Hepatology
- Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy
- (2010) Thomas Efferth et al. CURRENT DRUG TARGETS
- Predicting Drug–Drug Interactions: An FDA Perspective
- (2009) Lei Zhang et al. AAPS Journal
- Substrate Specificity, Regulation, and Polymorphism of Human Cytochrome P450 2B6
- (2009) Sui-Lin Mo et al. CURRENT DRUG METABOLISM
- The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America
- (2009) S. W. Grimm et al. DRUG METABOLISM AND DISPOSITION
- Associations betweenCYP2B6Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans
- (2009) David W. Haas et al. JOURNAL OF INFECTIOUS DISEASES
- CYP2B6: New Insights into a Historically Overlooked Cytochrome P450 Isozyme
- (2008) Hongbing Wang et al. CURRENT DRUG METABOLISM
- New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process
- (2008) Shiew-Mei Huang et al. JOURNAL OF CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started